Dudley Robert Michael
- SEC CIK
- 0001854161
No open-market purchases or sales filed in the past year.
Current role at each company
- RNAZ Transcode Therapeutics, Inc.Chief Executive Officeras of Oct 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dudley Robert Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 (view filing) | Sep 28 | 4 days | Dudley Robert MichaelChief Executive Officer | PPurchase | +98.0K | $0.51 | +$50.0K | +119.1%180.3K after | |
| Jun 22, 2023 (view filing) | Jun 20-21 | 2 days | Dudley Robert MichaelChief Executive Officer | PPurchase | +18.6K | $2.61 | +$48.6K | +29.2%82.3K after | 2 lots |
| Jun 14, 2023 (view filing) | Jun 9 | 5 days | Dudley Robert MichaelChief Executive Officer | PPurchase | +19.0K | $2.76 | +$52.4K | +45.1%61.2K after | Amended |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Dudley Robert MichaelChief Executive Officer | PPurchase | +20.0K | $1.15 | +$23.0K | +2.3%893.1K after | |
| Jun 1, 2022 (view filing) | May 27-31 | 5 days | Dudley Robert MichaelChief Executive Officer | PPurchase | +30.0K | $1.84 | +$55.3K | +3.6%873.1K after | 2 lots |